Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial.

Scientific Reports
Peter JanssensDjalila Mekahli

Abstract

It is unknown whether early diagnosis of autosomal dominant polycystic kidney disease (ADPKD) can enable earlier management and improve outcomes. We conducted a post hoc analysis of data from the TEMPO 3:4 trial. Subjects were stratified by ADPKD diagnosis at age ≤18 (childhood diagnosis [CD]) or>18 (adulthood diagnosis [AD]). Groups were compared for baseline characteristics and total kidney volume (TKV) growth and estimated glomerular filtration rate (eGFR) decline over 3 years. 294 CD and 1148 AD subjects were analyzed. At inclusion, CD subjects were younger (mean age 34.2 versus 39.8 years; p < 0.0001) and had better eGFR (mean ± SD 87.4 ± 23.9 versus 80.1 ± 20.7 mL/min/1.73 m2; p < 0.0001), while CD had more severe Mayo risk classification (p < 0.0001) and more PKD1 mutations (p = 0.003). No statistical differences were found in TKV or eGFR change. At study end, placebo-treated CD subjects had better eGFR than projected by a prediction equation (mean difference ±SD for observed versus predicted eGFR: 2.18 ± 10.7 mL/min/1.73 m2; p = 0.0475). However, these results are not confirmed when excluding stage 1 CKD. Whether CD subjects, despite their risk profile, have a slower disease course than predicted remains inconclusive. F...Continue Reading

References

Feb 10, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hanna ShalevDaniel Landau
Oct 26, 2007·Kidney International·J J GranthamK T Bae
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Apr 27, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Masaru HorioSeiichi Matsuo
Feb 22, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Vicente E TorresFrank S Czerwiec
Sep 10, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Imed HelalRobert W Schrier
Feb 22, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Arlene B ChapmanJared J Grantham
Feb 22, 2012·Nature Reviews. Nephrology·Imed HelalRobert W Schrier
Nov 6, 2012·The New England Journal of Medicine·Vicente E TorresUNKNOWN TEMPO 3:4 Trial Investigators
Mar 4, 2014·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Carsten Bergmann
Jun 7, 2014·Journal of the American Society of Nephrology : JASN·María V IrazabalUNKNOWN CRISP Investigators
Jul 16, 2014·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Jared J Grantham
Sep 30, 2014·Human Mutation·Emilie Cornec-Le GallClaude Férec
Nov 18, 2014·The New England Journal of Medicine·Robert W SchrierUNKNOWN HALT-PKD Trial Investigators
Jul 8, 2015·Journal of the American Society of Nephrology : JASN·Emilie Cornec-Le GallYannick Le Meur
Nov 5, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Fouad T Chebib, Vicente E Torres
Oct 4, 2016·Nature Reviews. Nephrology·Jared J Grantham, Vicente E Torres
Apr 6, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vicente E TorresUNKNOWN TEMPO 4:4 Trial Investigators
Nov 7, 2017·The New England Journal of Medicine·Vicente E TorresUNKNOWN REPRISE Trial Investigators
Jul 22, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Marie E EdwardsVicente E Torres
Sep 27, 2018·Clinical Journal of the American Society of Nephrology : CJASN·A Lianne MesschendorpUNKNOWN DIPAK Consortium
Oct 13, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vicente E Torres
Dec 27, 2018·The New England Journal of Medicine·Emily E GroopmanAli G Gharavi
Mar 30, 2019·Kidney International·Alan S L YuUNKNOWN Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP)
Sep 14, 2019·KI Reports·Stéphanie De RechterUNKNOWN ADPedKD Consortium

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Clinical Trials Mentioned

NCT02442674

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.